This proposal is designed to investigate the structure of the processed influenza viral antigenic moieties generated in infected cells which are recognized by human CD4+ T lymphocytes and to characterize the intracellular pathways by which viral proteins are processed and presented to human T lymphocytes. The proposed studies are an extension of our ongoing work on the characterization of the human T lymphocyte response to viral polypeptides. Our experimental approach is to first characterize the naturally processed influenza hemagglutinin and nucleocapsid peptides bound to HLA DRwll by chromatographic and mass spectroscopic means. In related studies, the impact of virus infection on the spectrum of self peptide bound to MHC class II molecules in infected cells will be assessed as well as the effect of viral antigen form, e.g. isolated viral polypeptides or de novo expressed viral protein, on the structure of the naturally processed peptides generated in antigen presenting cells. Efforts will be made to generate reagents which can tract the formation of peptide MHC complexes in the infected cell and to evaluate the effect of aminoacids outside of an antigenic epitope on the processing of the viral polypeptides and the formation of the antigenic peptide. In related studies, we will examine the pathways of viral glycoprotein targeting to the lysosomal antigen processing compartment and the mechanism by which cytosolic viral proteins are processed and presented in association with human MHC class II molecule. The experiments outlined in this proposal will provide new information on the structure of the naturally processed viral antigenic moieties recognized human T lymphocytes, and the mechanism by which they are generated in virus infected cells. Such information will be of immediate importance in viral vaccine design and of long-term significance in understanding immune function during infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI028317-09
Application #
2390324
Study Section
Experimental Virology Study Section (EVR)
Project Start
1991-07-01
Project End
1999-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
9
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Virginia
Department
Type
Organized Research Units
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Varga, Steven M; Braciale, Thomas J (2013) The adaptive immune response to respiratory syncytial virus. Curr Top Microbiol Immunol 372:155-71
Steigerwald-Mullen, P; Kurilla, M G; Braciale, T J (2000) Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1. J Virol 74:6748-59
Fan, R; Tykodi, S S; Braciale, T J (2000) Recognition of a sequestered self peptide by influenza virus-specific CD8+ cytolytic T lymphocytes. J Immunol 164:1669-80
Yang, B; Braciale, T J (1995) Characteristics of ATP-dependent peptide transport in isolated microsomes. J Immunol 155:3889-96
Cao, W; Myers-Powell, B A; Braciale, T J (1994) Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes. J Exp Med 179:195-202
Kittlesen, D J; Brown, L R; Braciale, V L et al. (1993) Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants. J Exp Med 177:1021-30
Graham, M B; Dalton, D K; Giltinan, D et al. (1993) Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J Exp Med 178:1725-32
Hahn, Y S; Braciale, V L; Braciale, T J (1991) Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglu J Exp Med 174:733-6
Brown, L R; Nygard, N R; Graham, M B et al. (1991) Recognition of the influenza hemagglutinin by class II MHC-restricted T lymphocytes and antibodies. I. Site definition and implications for antigen presentation and T lymphocyte recognition. J Immunol 147:2677-84
Nygard, N R; Bono, C; Brown, L R et al. (1991) Antibody recognition of an immunogenic influenza hemagglutinin-human leukocyte antigen class II complex. J Exp Med 174:243-51

Showing the most recent 10 out of 11 publications